Diagnostics News and Research

RSS

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.

9 Aug 2023

Outcome markers in COPD patients with COVID-19

Researchers identify potential markers for severe COVID-19 and death in COPD patients.

8 Aug 2023

Medical grade adhesives for medical device manufacturing

In this interview, Master Bond describes the features and benefits of medical grade adhesives for medical device manufacturing.

From Master Bond Inc. 8 Aug 2023

AI-powered Schistoscope could revolutionize diagnosis of parasitic disease

Schistosomiasis, a parasitic disease affecting millions worldwide, poses a significant public health and economic burden, particularly in impoverished regions.

8 Aug 2023

AI-based predictive tool could help guide treatment of cancer

Researchers at Dana-Farber Cancer Institute have created an AI-based tool that uses tumor gene sequencing data to predict the primary source of a patient's cancer.

7 Aug 2023

Researchers develop new method to find mutations in pediatric brain tumors

Researchers at Uppsala university have developed a new method to find mutations in brain tumors in children.

7 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Researchers explore the distinguishing features of MIS-C as compared to other inflammatory-infectious syndromes in children.

4 Aug 2023

GEMINI test shows promise for early detection of lung cancer

Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and other cancers.

4 Aug 2023

Gene expression ratio linked to prognosis in solid tumors

A Ludwig Cancer Research study has identified a pair of genes whose expression by a type of immune cell within tumors is predictive of outcomes for cancer patients and is linked to a vast network of gene expression programs, engaged by multiple cell types in the tumor microenvironment, that control human cancers.

3 Aug 2023

Point-of-care rapid diagnostics for detecting SARS-CoV-2 in exhaled breath

Researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of SARS-CoV-2 in exhaled breath.

3 Aug 2023

Hepatitis C cure still linked to higher mortality rates

Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population - between 3 and 14 times higher depending on liver disease stage, finds the largest study of its kind published by The BMJ today.

2 Aug 2023

ICI therapy linked to unique immune response in arthritis

Immune checkpoint inhibitor (ICI) therapies used to treat cancer come with the risk of adverse autoimmune responses, including arthritis that can persist for years and require joint replacement surgery.

1 Aug 2023

Scientists develop breakthrough technology for detecting protein modifications

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

1 Aug 2023

Computer algorithms could help track and diagnose periodontal disease

Periodontal disease is a growing public health issue in the United States as the nation's population ages, yet it's underdiagnosed and undertreated.

1 Aug 2023

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

1 Aug 2023

Archer further enhances biochip gFET design for advanced sensing and sends to commercial foundry partner

Archer Materials Limited (“Archer”, the “Company”), a semiconductor company advancing the quantum computing and medical diagnostics industries, has developed a next generation biochip fabrication to better detect and control disease samples on a single graphene field effect transistor (“gFET”) design.

1 Aug 2023